7 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Innovative Nanoformulation of Antimicrobial Peptides to Treat Bacterial Infectious Diseases (FORMAMP)
Date du début: 1 déc. 2013, Date de fin: 30 nov. 2017,
Resistance to traditional antibiotics is a rapidly increasing problem that in a few years could make infections impossible to treat and bring the state of medical care back to the pre-antibiotic era from the beginning of the last century. Antimicrobial peptides (AMPs) have a huge potential as new therapeutics against infectious diseases as they are less prone to induce resistance due to their fast ...
Voir le projet
18
Participants partenaires
TERMINÉ
More Affordable Aircraft structure through eXtended, Integrated, and Mature nUmerical Sizing (MAAXIMUS)
Date du début: 1 avr. 2008, Date de fin: 30 sept. 2016,
Even though composite materials are more and more used in modern airframes, many significant improvements are still achievable. Firstly, the substitution of the assembly of many small composite parts by a single one-shot large part provides additional weight reduction. Secondly, the final assembly line process must be adapted to composite properties (lack of ductility, stiffness). Thirdly, if the ...
Voir le projet
60
Participants partenaires
TERMINÉ
Angiogenesis-inducing Bioactive and Bioresponsive Scaffolds in Tissue Enginering (AngioScaff)
Date du début: 1 déc. 2008, Date de fin: 30 nov. 2012,
Angiogenesis underlies almost all biological processes of morphogenesis, including those in tissue repair and regeneration. Physiological angiogenesis is controlled by a complex interplay between cells and their environment: the extracellular matrix (ECM) provides signaling via numerous ECM adhesion molecules and growth factors bound to ECM polysaccharide components; and cells locally degrade and ...
Voir le projet
33
Participants partenaires
TERMINÉ
Strategic Networking of RDI Programmes in Construction and Operation of Buildings (ERACOBUILD)
Date du début: 1 nov. 2008, Date de fin: 30 avr. 2012,
ERACOBUILD aims at strengthening and enlarging the strategic networking of RDI programmes in the field of “construction and operation of buildings” initiated in the previous ERABUILD coordination action. ERACOBUILD gathers 34 programme owners or managers coming from 17 EU Members States, 4 Associated Countries and 1 European Region. The new countries will benefit from the experience and results o ...
Voir le projet
35
Participants partenaires
TERMINÉ
Aerodynamic loads estimation at extremes of the flight envelope (ALEF)
Date du début: 1 mai 2009, Date de fin: 30 avr. 2012,
"ALEF's objective is to enable the European aeronautical industry to create complete aerodynamic models of their aircraft based on numerical simulation approaches within the respective development processes. I.e. ALEF will kick-off a paradigm shift from greater confidence in experimentally measured loads data to greater confidence in computational results. Beyond the scope of ALEF this paradigm sh ...
Voir le projet
20
Participants partenaires
TERMINÉ
Innovative technology for low-cost production of photovoltaic solar cells (SUNRISE)
Date du début: 1 juil. 2009, Date de fin: 31 déc. 2011,
Background
Photovoltaic (PV) solar energy provides a potential alternative to energy sources that produce CO2 emissions. Today, PV solar cells are produced primarily in four countries: Japan, China, USA, and Germany, with Japan having the largest share of global production, at nearly 40%.
Reducing the manufacturing cost of PV solar cells and/or increasi ...
Voir le projet
1
Participant partenaire
TERMINÉ
"DIAbetes type 1 PRediction, Early Pathogenesis and Prevention" (DIAPREPP)
Date du début: 1 avr. 2008, Date de fin: 31 août 2011,
"The earliest currently identifiable process in the pathogenesis of type 1 diabetes (T1D) is the development of autoimmunity to islet beta cells in the form of autoantibodies. Hindering attempts to prevent autoimmune T1D, the aetiology and pathogenesis of the islet auto-immunization, including whether it is preceded by metabolic abnormalities and cell-mediated autoimmunity, is still poorly underst ...
Voir le projet